封面
市场调查报告书
商品编码
1619472

2024 年乳房切片全球市场报告

Breast Biopsy Global Market Report 2024

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

乳房切片市场规模预计在未来几年将强劲成长。 2028年,这一数字将以7.4%的复合年增长率成长至18.9亿美元。预测期内的成长可归因于医疗保健基础设施的进步、个人化医疗的扩展、开发中地区获得医疗保健的机会的增加、支持性监管和报销措施以及远端医疗和远距离诊断的兴起。主要趋势包括机器人技术在切片检查程序中的整合、家庭切片检查套件的增长、基因组切片检查的重要性日益增加、强调以患者为中心的护理模式、使用区块链确保资料安全以及切片检查。

乳癌盛行率的增加预计将在未来几年推动乳房切片市场的成长。乳癌是一种始于乳腺组织细胞的恶性,如果不及时治疗,可能会扩散到身体的其他部位。导致乳癌发生率上升的因素包括预期寿命延长、检测方法改善以及对该疾病的认识提高。乳房切片涉及从乳房可疑区域采集组织样本,以诊断和评估乳癌的特征。例如,2023年1月,美国癌症协会报告称,美国女性新发生侵袭性乳癌病例数从2021年的约281,550例增加到2023年的297,790例。因此,乳癌盛行率的增加推动了乳房切片市场的扩张。

乳房切片市场的主要企业专注于开发创新解决方案,例如真空辅助乳房切片系统,以改善良性病变患者的照护。真空辅助乳房切片系统是医疗设备,透过单针插入,利用吸力从可疑乳房区域采集多个组织样本。例如,2022 年 8 月,美国医疗设备製造商 Devicor Medical Products, Inc. 推出了 Mammotome Revolve EX 双真空辅助乳房切片系统。该系统具有双真空机制,可增强组织收集,并可实现大容量采样和更高的精度。符合人体工学的设计包括提高可操作性的旋转探头和减少患者不适的一次性插入过程。此外,该系统整合了即时成像,以实现精确定位和高效的切片检查程序。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球乳房切片市场:驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球乳房切片市场表现:规模与成长,2018-2023
  • 全球乳房切片市场预测:规模与成长,2023-2028 年、2033 年

第六章 市场细分

  • 全球乳房切片市场:按类型、绩效和预测,2018-2023、2023-2028、2033
  • 切片穿刺针
  • 引导系统
  • 切片检查台
  • 定位线
  • 检测试剂套件
  • 液态生物检体仪器
  • 其他的
  • 全球乳房切片市场:影像引导技术的表现与预测,2018-2023、2023-2028、2033
  • 磁振造影(MRI) 引导乳房切片
  • 超音波引导下乳房切片
  • 乳房X光摄影引导切片检查定位活检
  • 电脑断层扫描 (CT) 引导切片检查
  • 其他的
  • 全球乳房切片市场:按程序、绩效和预测,2018-2023、2023-2028、2033
  • 乳房切片
  • 开放性手术乳房切片
  • 乳房切片
  • 全球乳房切片市场:按应用、性能和预测,2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 诊断中心
  • 其他的

第 7 章 区域/国家分析

  • 全球乳房切片市场:按地区、绩效及预测,2018-2023、2023-2028、2033
  • 全球乳房切片市场:按国家、绩效及预测,2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 乳房切片市场:竞争格局
  • 乳房切片市场:公司简介
    • Medtronic PLC
    • Siemens Healthineers AG
    • Fujifilm Holdings Corporation
    • Becton Dickinson and Company(BD)
    • Koninklijke Philips

第三十一章 其他重大及创新企业

  • GE HealthCare Technologies Inc.
  • Hologic Inc.
  • The Cooper Companies Inc.
  • Merit Medical Systems
  • Argon Medical Devices
  • Canon Medical Systems Corporation
  • Devicor Medical Products Inc.
  • Mermaid Medical Group
  • Planmed Oy
  • Menarini-Silicon Biosystems
  • Seno Medical Instruments Inc.
  • Surgical Innovations Group
  • Sterylab Srl
  • Dilon Technologies Inc.
  • INRAD Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20503

A breast biopsy is a medical procedure in which a small sample of breast tissue is removed and examined under a microscope to determine if it is cancerous or benign. It is typically performed when a lump or abnormality is detected in the breast through imaging tests or physical exams. The biopsy can be done using various methods, such as needle biopsy or surgical biopsy, often guided by imaging techniques such as ultrasound, and mammography.

The main types of breast biopsy are biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Biopsy needles are specialized medical tools used to extract tissue samples from the breast for examination. The image-guided technologies are magnetic resonance imaging (MRI)-guided breast biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic biopsy, computed tomography (CT)-guided biopsy, and others, and the procedures are needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The applications include hospitals, clinics, diagnostic centers, and others.

The breast biopsy market research report is one of a series of new reports from The Business Research Company that provides breast biopsy market statistics, including breast biopsy industry global market size, regional shares, competitors with a breast biopsy market share, detailed breast biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the breast biopsy industry. This breast biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast biopsy market size has grown strongly in recent years. It will grow from $1.33 billion in 2023 to $1.42 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the increasing prevalence of breast cancer, the aging population, expanding awareness programs, rising healthcare expenditure, and a shift toward outpatient and ambulatory settings.

The breast biopsy market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to advancements in healthcare infrastructure, the expansion of personalized medicine, increased healthcare access in developing regions, supportive regulatory and reimbursement policies, and the rise of telemedicine and remote diagnostics. Key trends include the integration of robotics in biopsy procedures, growth in home-based biopsy kits, the increasing importance of genomic biopsies, a focus on patient-centered care models, the use of blockchain for data security, and an emphasis on post-biopsy monitoring tools.

The increasing prevalence of breast cancer is expected to drive the growth of the breast biopsy market in the future. Breast cancer is a malignant tumor that originates in breast tissue cells and can spread to other parts of the body if not treated promptly. Contributing factors to the rise in breast cancer prevalence include longer life expectancy, improved detection methods, and heightened awareness of the disease. A breast biopsy involves obtaining tissue samples from suspicious areas in the breast to diagnose and assess the characteristics of breast cancer. For example, in January 2023, the American Cancer Society reported that the number of new invasive breast cancer cases among American women increased from approximately 281,550 in 2021 to 297,790 in 2023. Consequently, the growing prevalence of breast cancer is fueling the expansion of the breast biopsy market.

Major companies in the breast biopsy market are focusing on developing innovative solutions, such as vacuum-assisted breast biopsy systems, to improve care for patients with benign lesions. A vacuum-assisted breast biopsy system is a medical device that uses suction to obtain multiple tissue samples from a suspicious breast area through a single needle insertion. For example, in August 2022, Devicor Medical Products, Inc., a US-based medical device company, introduced the Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System. This system features a dual vacuum mechanism for enhanced tissue collection, providing high-volume sampling and greater accuracy. Its ergonomic design includes a rotating probe for better maneuverability and a single insertion process to reduce patient discomfort. Additionally, the system integrates real-time imaging for precise targeting and efficient biopsy procedures.

In May 2024, Lunit Inc., a South Korea-based medical software company, acquired Volpara Health Technologies Ltd. for an undisclosed amount. This acquisition will enable Lunit Inc. to expand its portfolio with advanced breast imaging and analysis technologies, thereby enhancing its capabilities in early cancer detection. Volpara Health Technologies Ltd., based in New Zealand, is a provider of breast biopsy solutions.

Major companies operating in the breast biopsy market are Medtronic PLC, Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), Koninklijke Philips, GE HealthCare Technologies Inc., Hologic Inc., The Cooper Companies Inc., Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc., Mermaid Medical Group, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc., Surgical Innovations Group, Sterylab Srl, Dilon Technologies Inc., INRAD Inc., Promaxo Inc.

North America was the largest region in the breast biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The breast biopsy market consists of revenues earned by providing services such as biopsy procedures, consultations, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast biopsy market also includes sales of biodegradable tissue markers, and semi-automated and fully automated biopsy needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Biopsy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on breast biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The breast biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Biopsy Needles; Guidance Systems; Biopsy Tables; Localization Wires; Assay Kits; Liquid Biopsy Instruments; Other Types
  • 2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy; Ultrasound Guided Breast Biopsy; Mammography Guided Stereotactic Biopsy; Computed Tomography (CT) Guided Biopsy; Other Image Guided Breast Biopsy
  • 3) By Procedure: Needle Breast Biopsy; Open Surgical Breast Biopsy; Liquid Breast Biopsy
  • 4) By Application: Hospitals; Clinics; Diagnostic Centers; Other Applications
  • Companies Mentioned: Medtronic PLC; Siemens Healthineers AG; Fujifilm Holdings Corporation; Becton Dickinson and Company (BD); Koninklijke Philips
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Breast Biopsy Market Characteristics

3. Breast Biopsy Market Trends And Strategies

4. Breast Biopsy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Breast Biopsy Market Size and Growth

  • 5.1. Global Breast Biopsy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Breast Biopsy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Breast Biopsy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Breast Biopsy Market Segmentation

  • 6.1. Global Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits
  • Liquid Biopsy Instruments
  • Other Types
  • 6.2. Global Breast Biopsy Market, Segmentation By Image Guided Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Magnetic Resonance Imaging (MRI) Guided Breast Biopsy
  • Ultrasound Guided Breast Biopsy
  • Mammography Guided Stereotactic Biopsy
  • Computed Tomography (CT) Guided Biopsy
  • Other Image Guided Breast Biopsy
  • 6.3. Global Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Needle Breast Biopsy
  • Open Surgical Breast Biopsy
  • Liquid Breast Biopsy
  • 6.4. Global Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Other Applications

7. Breast Biopsy Market Regional And Country Analysis

  • 7.1. Global Breast Biopsy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Breast Biopsy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Breast Biopsy Market

  • 8.1. Asia-Pacific Breast Biopsy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Breast Biopsy Market

  • 9.1. China Breast Biopsy Market Overview
  • 9.2. China Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Breast Biopsy Market

  • 10.1. India Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Breast Biopsy Market

  • 11.1. Japan Breast Biopsy Market Overview
  • 11.2. Japan Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Breast Biopsy Market

  • 12.1. Australia Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Breast Biopsy Market

  • 13.1. Indonesia Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Breast Biopsy Market

  • 14.1. South Korea Breast Biopsy Market Overview
  • 14.2. South Korea Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Breast Biopsy Market

  • 15.1. Western Europe Breast Biopsy Market Overview
  • 15.2. Western Europe Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Breast Biopsy Market

  • 16.1. UK Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Breast Biopsy Market

  • 17.1. Germany Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Breast Biopsy Market

  • 18.1. France Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Breast Biopsy Market

  • 19.1. Italy Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Breast Biopsy Market

  • 20.1. Spain Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Breast Biopsy Market

  • 21.1. Eastern Europe Breast Biopsy Market Overview
  • 21.2. Eastern Europe Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Breast Biopsy Market

  • 22.1. Russia Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Breast Biopsy Market

  • 23.1. North America Breast Biopsy Market Overview
  • 23.2. North America Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Breast Biopsy Market

  • 24.1. USA Breast Biopsy Market Overview
  • 24.2. USA Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Breast Biopsy Market

  • 25.1. Canada Breast Biopsy Market Overview
  • 25.2. Canada Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Breast Biopsy Market

  • 26.1. South America Breast Biopsy Market Overview
  • 26.2. South America Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Breast Biopsy Market

  • 27.1. Brazil Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Breast Biopsy Market

  • 28.1. Middle East Breast Biopsy Market Overview
  • 28.2. Middle East Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Breast Biopsy Market

  • 29.1. Africa Breast Biopsy Market Overview
  • 29.2. Africa Breast Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Breast Biopsy Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Breast Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Breast Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Breast Biopsy Market Competitive Landscape
  • 30.2. Breast Biopsy Market Company Profiles
    • 30.2.1. Medtronic PLC
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Siemens Healthineers AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Fujifilm Holdings Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company (BD)
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Koninklijke Philips
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Breast Biopsy Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc.
  • 31.2. Hologic Inc.
  • 31.3. The Cooper Companies Inc.
  • 31.4. Merit Medical Systems
  • 31.5. Argon Medical Devices
  • 31.6. Canon Medical Systems Corporation
  • 31.7. Devicor Medical Products Inc.
  • 31.8. Mermaid Medical Group
  • 31.9. Planmed Oy
  • 31.10. Menarini-Silicon Biosystems
  • 31.11. Seno Medical Instruments Inc.
  • 31.12. Surgical Innovations Group
  • 31.13. Sterylab Srl
  • 31.14. Dilon Technologies Inc.
  • 31.15. INRAD Inc.

32. Global Breast Biopsy Market Competitive Benchmarking

33. Global Breast Biopsy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Breast Biopsy Market

35. Breast Biopsy Market Future Outlook and Potential Analysis

  • 35.1 Breast Biopsy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Breast Biopsy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Breast Biopsy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer